Repository logo
Institutional Repository
Communities & Collections
Browse
Quick Links
  • Central Library
  • Digital Library
  • BHU Website
  • BHU Theses @ Shodhganga
  • BHU IRINS
  • Login
  • English
  • العربية
  • বাংলা
  • Català
  • Čeština
  • Deutsch
  • Ελληνικά
  • Español
  • Suomi
  • Français
  • Gàidhlig
  • हिंदी
  • Magyar
  • Italiano
  • Қазақ
  • Latviešu
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Српски
  • Svenska
  • Türkçe
  • Yкраї́нська
  • Tiếng Việt
Log In
New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Akshay Kumar Jha"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    PublicationReview
    A review on integrated design and application of stimuli-responsive ZIF-8 metal-organic frameworks for breast cancer theranostics
    (Elsevier B.V., 2025) Akshay Kumar Jha; Sanchit Arora; Rohan Chand Sahu; Dinesh Kumar; S. Kumar Singh; Ashish Kumar Kumar Agrawal
    Breast cancer continues to be a predominant cause of death among women globally, necessitating the development of more effective and targeted treatment strategies. While current therapies have shown efficacy, they are often associated with notable adverse effects and inadequate tumor targeting. This review explores the potential of stimuli-responsive zeolitic imidazole framework-8 (ZIF-8) metal-organic frameworks (MOFs) in the treatment of breast cancer. Composed of zinc ions and imidazolate linkers, ZIF-8’s structure offers pH-sensitive degradation, making it ideal for precise medication delivery in the acidic tumor microenvironment. We investigate various synthesis methods and emphasize the advantages of ZIF-8 in enhancing drug bioavailability and precision targeting. The stimuli-responsive properties of ZIF-8 MOFs—such as responsiveness to pH, light, temperature, ultrasound, redox conditions, and enzymes—enable controlled and site-specific drug release. Furthermore, we examine the integration of ZIF-8 MOFs with existing breast cancer therapies and their applications in diagnostics and imaging. Consideration is also given to the biocompatibility of ZIF-8 to ensure safe and effective clinical use. This review article offers a comprehensive analysis of the function of stimuli-responsive ZIF-8 MOFs in transforming breast cancer therapy and facilitating novel treatment approaches. © 2025 The Authors
An Initiative by BHU – Central Library
Powered by Dspace